What is Cholangiocarcinoma? Understand the Causes, Progression and Patient Outcomes

Cholangiocarcinoma, commonly known as bile duct cancer (膽管癌), is a rare but aggressive malignancy that originates in the bile ducts. The bile ducts are an essential part of the digestive system, responsible for carrying bile — a fluid produced by the liver — to the gallbladder and small intestine, where it aids digestion. Although relatively uncommon, cholangiocarcinoma is a serious condition with a high mortality rate, especially when diagnosed in its advanced stages.  

What Is Cholangiocarcinoma?    

Cholangiocarcinoma is a type of cancer that develops in the bile ducts, which are part of the hepato-biliary system. The biliary system consists of tubes transporting bile from the liver to the duodenum (the 1st part of the small intestine). Cholangiocarcinoma can occur in different parts of this system, and it is categorised based on its location: 

1. Intrahepatic Cholangiocarcinoma

• This type arises in the bile ducts located within the liver

• It accounts for about 10-20% of all cholangiocarcinoma cases

• Symptoms often overlap with liver cancer and include abdominal pain, fatigue, and weight loss

2. Perihilar Cholangiocarcinoma (Klatskin Tumours)

• This type occurs at the junction where the bile ducts exit the liver and join the larger bile duct that leads to the small intestine

• Perihilar cholangiocarcinoma is the most common form, accounting for 50-60% of cases

• It tends to block bile flow, causing jaundice and yellowing skin and eyes

3. Distal Cholangiocarcinoma

• This occurs in the bile ducts closer to the small intestine

• It accounts for 20-30% of cases

• It often presents with symptoms like jaundice and digestive issues due to bile duct obstruction

Risk Factors for Cholangiocarcinoma 

Several factors can increase the risk of developing bile duct cancer: 

• Chronic Bile Duct Inflammation: Conditions like primary sclerosing cholangitis (PSC), which causes scarring and inflammation of the bile ducts, increase the risk

• Liver Diseases: Chronic hepatitis B or C infections, cirrhosis, or fatty liver disease are associated with cholangiocarcinoma

• Parasitic Infections: Liver fluke infections, common in parts of Southeast Asia due to consumption of undercooked fish, are a known risk factor

• Congenital Abnormalities: Biliary system abnormalities, such as choledochal cysts, increase susceptibility to cancer

• Age and Gender: Cholangiocarcinoma is more common in individuals over 50 and occurs slightly more often in males

• Toxins and Chemicals: Long-term exposure to certain chemicals, such as thorium dioxide or nitrosamines, may contribute to the disease

• Alcoholic Beverage Consumption and Smoking: Both have been implicated in increasing the risk of developing cholangiocarcinoma 

• Diabetes and Obesity: Also increase cholangiocarcinoma risk 

Symptoms of Cholangiocarcinoma 

Cholangiocarcinoma often presents with vague symptoms, making early diagnosis challenging. Common symptoms include: 

• Jaundice: Yellowing of the skin and eyes due to bile duct obstruction

• Abdominal Pain: Often in the upper right side of the abdomen

• Unexplained Weight Loss: A common symptom in many cancers, including cholangiocarcinoma

• Fatigue: Persistent tiredness and low energy levels

• Dark Urine and Pale Stools: Caused by bile flow disruption or obstruction

• Itchy Skin: A result of bile buildup in the bloodstream

• Nausea and Vomiting: Digestive disturbances due to bile duct blockage

Diagnosis of Cholangiocarcinoma 

Since symptoms are non-specific, diagnosing cholangiocarcinoma often requires multiple tests, including: 

• Imaging Tests: Ultrasound, CT scan, or MRI to visualise bile ducts and detect abnormalities

• Blood Tests: Assess liver function and check for tumour markers like CA 19-9

• Biopsy: A tissue sample from the bile duct is examined to confirm the cancer type
• Endoscopic Procedures: Techniques like ERCP (endoscopic retrograde cholangiopancreatography) may be used to obtain bile duct samples and relieve obstruction
   

Final Stages of Cholangiocarcinoma and Its Challenges?  

Cholangiocarcinoma is an aggressive cancer with a poor prognosis, particularly when diagnosed at an advanced stage. The progression of the disease, coupled with its complications, often leads to death. Below are the most common causes of mortality in cholangiocarcinoma patients: 

1. Liver Failure

• Extensive tumour growth in the liver

• Obstruction of bile flow, leading to bile buildup and liver damage

• Secondary infections or inflammation caused by bile duct blockages

• Symptoms of liver failure include jaundice, confusion (hepatic encephalopathy), swelling in the abdomen (ascites), and bleeding disorders

2. Biliary Sepsis (Cholangitis)

• Bile duct blockages caused by tumours can lead to infections known as cholangitis. When bacteria infect the stagnant bile, it can cause life-threatening sepsis (a severe systemic infection)

• Sepsis can rapidly overwhelm the body’s immune defenses, leading to organ failure and death if not treated promptly

• Symptoms of biliary sepsis include high fever, chills, abdominal pain, jaundice, confusion and low blood pressure

3. Metastasis to Other Organs

• Respiratory failure if it spreads to the lungs

• Bowel obstruction if the peritoneum is involved 

• Cachexia (severe weight loss and muscle wasting) due to the body’s inability to absorb nutrients properly

• The widespread nature of metastatic cancer makes it difficult to control, even with aggressive treatments

4. Obstruction of Bile Flow

• Severe jaundice

• Pruritus (intense itching)

• Liver inflammation and damage

• If untreated, prolonged bile obstruction can result in liver failure, infections, and death

5. Complications from Treatment

• Surgical Complications: Surgery to remove bile duct tumours is complex and can result in bleeding, infections, or bile leaks

• Chemotherapy Side Effects: Chemotherapy can weaken the immune system, increasing the risk of infections. It may also damage healthy organs

• Radiation Therapy: While effective in shrinking tumours, radiation can harm surrounding tissues and cause long-term complications

• In some cases, the side effects of treatment can accelerate the patient’s decline

6. Cachexia and Nutritional Deficiencies

• Advanced cholangiocarcinoma often leads to cachexia, a condition characterised by severe weight loss, muscle wasting, and weakness

• Bile duct blockages disrupt the digestion and absorption of fats and fat-soluble vitamins, causing malnutrition

• As the body’s energy reserves and nutrients are depleted, patients may become too weak to fight the disease or recover from treatment complications

7. Emotional and Psychological Factors

• The toll of living with a terminal illness can lead to depression, anxiety, and a loss of will to live

• Emotional distress may exacerbate physical symptoms, contributing to a decline in overall health

Prognosis and End-of-Life Care 

Cholangiocarcinoma has a poor prognosis, with a 5-year survival rate of approximately 10-15% for advanced cases. Early-stage cancer has better outcomes, especially when the tumour is localised and surgically resectable. However, most cases are diagnosed late due to the lack of specific symptoms. 

In advanced stages, treatment focuses on palliative care, which aims to relieve symptoms, improve quality of life, and provide emotional and psychological support. Common aspects of end-of-life care for cholangiocarcinoma patients include: 

• Pain Management: Using medications like opioids to alleviate chronic pain

• Symptom Relief: Procedures like stent placement to relieve bile duct obstruction and reduce jaundice

• Psychological Support: Counselling and emotional support for patients and their families

• Hospice Care: Providing comfort and dignity during the final stages of life

Cholangiocarcinoma is a challenging and aggressive cancer with a high mortality rate. Understanding the disease, its progression, and the challenges patients face can help raise awareness and improve early detection efforts. While the outlook for advanced cholangiocarcinoma remains poor, advancements in research, targeted therapies, and palliative care are providing hope for better management of the disease. 

Suppose you or a loved one is facing cholangiocarcinoma. In that case, it is crucial to work closely with a healthcare team to explore all available treatment options and ensure that the patient’s quality of life is prioritised. 

Book an Appointment